Advertisement

Topics

Semafore Pharmaceuticals Inc. Company Profile

12:47 EST 20th February 2017 | BioPortfolio

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus -- cancer. Semafore is a leader in the development of PI3K inhibitors and one of the first biopharmaceutical companies to focus on both PI3K and PTEN. The company has successfully discovered and is developing a portfolio of drug candidates addressing these targets.


News Articles [1169 Associated News Articles listed on BioPortfolio]

M&As this week: Dendreon Pharmaceuticals, Agile Pharma, Takeda Pharmaceutical Company

Valeant Pharmaceuticals International subsidiary Dendreon Pharmaceuticals will be acquired by Sanpower Group.

Deals this week: Sucampo Pharmaceuticals, Satsuma Pharmaceuticals, Nanjing Hicin Pharmaceutical

Sucampo Pharmaceuticals has made plans for a private placement of convertible senior notes, due 2021.

Easton Pharmaceuticals and Partner BMV Medica Announce Closing Of First Distribution Agreement For Three Exclusively Licensed Women's Health Products: VagiSense, AmnioSense and Gynofit With Windsor Pharmaceuticals For Central America and The Caribbean /

TORONTO, ON -- (Marketwired) -- 10/31/16 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has closed its first Sales & Distribution agreement with Windsor Pharmaceuticals SA for three ...

Delisting and regulator's inaction failed to improve market capitalization of pharma entities

The Bombay Stock Exchange (BSE) authorities have suspended major companies from pharmaceutical segment like Elder Pharmaceuticals, Surya Pharmaceuticals, Plethico Pharmaceuticals, Twilight Litaka, Dr

Deals this week: Rigel Pharmaceuticals, VANC Pharmaceuticals, Provectus Biopharmaceuticals

US-based clinical-stage bio-technology company Rigel Pharmaceuticals has announced the pricing for its underwritten public offering of 20 million shares to be $2 a share.

Ritter Pharmaceuticals Announces Collaboration with University of British Columbia to Explore ...

LOS ANGELES, CA--(Marketwired - Feb 13, 2017) - Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of Read more...

BRIEF-Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene Corporation

* Acetylon Pharmaceuticals -Regenacy Pharmaceuticals to be launched by Acetylon Pharmaceuticals and Celgene Corporation agrees to complete acquisition of acetylon

Ritter Pharmaceuticals Phase 2a Lactose Intolerance Clinical Trial Microbiome Data, Published ...

LOS ANGELES, CA--(Marketwired - Jan 3, 2017) - Ritter Pharmaceuticals, Inc. ( NASDAQ : RTTR) ("Ritter Pharmaceuticals" or the "Company"), a developer of Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [144 Associated PubMed Articles listed on BioPortfolio]

Biotransformation of pharmaceuticals by ammonia oxidizing bacteria in wastewater treatment processes.

Pharmaceutical residues could potentially pose detrimental effects on aquatic ecosystems and human health, with wastewater treatment being one of the major pathways for pharmaceuticals to enter into t...

Progress Confirmed for Pharmaceuticals in 2016.

n/a.

Temporal and spatial behavior of pharmaceuticals in Narragansett Bay, Rhode Island, United States.

The behavior and fate of pharmaceutical ingredients in coastal marine ecosystems is not well understood. To address this, the spatial and temporal distribution of 15 high volume pharmaceuticals were m...

Announcing the 2016 Pharmaceuticals Travel Award for Young Investigators.

For the first time in its short history, our journal is able, this year, to support a young researcher in the field of medicinal chemistry by offering a travel grant of 800 CHF.[...].

Estimation of amount of selected pharmaceuticals sorbed onto digested sludge from wastewater treatment plant Bratislava-Petržalka.

Antibiotics and antidepressants are among the most successful drugs used for human therapy. Their concentration in influent on WWTP is relative high and there can be removed by biodegradation or sorpt...

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

This is a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site Study to Evaluate the Therapeutic Equivalence of a Generic Pimecrolimus Cream, 1% (Glenmark Pharmaceut...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 300 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 300 mg (Apsen Pharmaceuticals A / S.), after single dose oral administration to healthy subjects of both sexes, ...

Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of Dexibuprofen 200 mg.

To evaluate the interaction of food on the pharmacokinetics of Dexibuprofen 200 mg (Apsen Pharmaceuticals A / S.) after single dose oral administration to healthy subjects of both sexes, u...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Fluoxetine Tablet Under Fasting Conditions

Subjects to compare the single dose bioavailability of Torrent's Fluoxetine Tablets 20 mg and Sarafem® 20 mg Tablets of Warner Chilcott LLC, USA. Dosing periods of studies were separated ...

Companies [1235 Associated Companies listed on BioPortfolio]

Semafore Pharmaceuticals Inc.

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple ...

Semafore Pharmaceuticals

Semafore Pharmaceuticals is a private, clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibitors targe...

Semafore Pharmaceuticals, Inc.

Founded in 2000, Semafore Pharmaceuticals is a clinical-stage biotechnology company dedicated to the discovery and development of novel small molecule signal transduction inhibito...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Semafore Pharmaceuticals Inc." on BioPortfolio

We have published hundreds of Semafore Pharmaceuticals Inc. news stories on BioPortfolio along with dozens of Semafore Pharmaceuticals Inc. Clinical Trials and PubMed Articles about Semafore Pharmaceuticals Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Semafore Pharmaceuticals Inc. Companies in our database. You can also find out about relevant Semafore Pharmaceuticals Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record